Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.18)
# 2,840
Out of 5,090 analysts
334
Total ratings
39.35%
Success rate
-3.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $56.88 | +40.65% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $63.33 | +18.43% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $81.68 | -20.42% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $11.12 | +25.90% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $7.02 | +1,324.50% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $30.84 | +45.91% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $28.13 | +166.62% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $21.50 | +39.53% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $18.31 | +140.31% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $22.26 | -55.08% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $25.47 | -60.74% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.61 | +212.17% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $10.92 | +1,044.69% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $17.56 | -14.58% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.14 | +338.60% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $7.80 | -35.90% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.95 | +26.58% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $9.35 | +60.43% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $20.28 | +121.89% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.42 | +23.97% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.88 | +481.40% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.66 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.78 | +293.26% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $3.74 | -19.79% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.53 | +280.52% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.59 | +466.04% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.88 | +207.69% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $68,930,000 | $3.08 | +2,237,986,912.99% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.46 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $56.88
Upside: +40.65%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $63.33
Upside: +18.43%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $81.68
Upside: -20.42%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $11.12
Upside: +25.90%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $7.02
Upside: +1,324.50%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $30.84
Upside: +45.91%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $28.13
Upside: +166.62%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $21.50
Upside: +39.53%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $18.31
Upside: +140.31%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $22.26
Upside: -55.08%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $25.47
Upside: -60.74%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $9.61
Upside: +212.17%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $10.92
Upside: +1,044.69%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $17.56
Upside: -14.58%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.14
Upside: +338.60%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $7.80
Upside: -35.90%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $3.95
Upside: +26.58%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $9.35
Upside: +60.43%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.28
Upside: +121.89%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.42
Upside: +23.97%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $6.88
Upside: +481.40%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.66
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.78
Upside: +293.26%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $3.74
Upside: -19.79%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.53
Upside: +280.52%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.59
Upside: +466.04%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.88
Upside: +207.69%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $68,930,000
Current: $3.08
Upside: +2,237,986,912.99%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $5.46
Upside: -